Antony Loebel - Chief Medical Officer and President of Clinical Development @ Seaport Therapeutics

Overview

CB Rank (Person)

Primary Job Title Chief Medical Officer and President of Clinical Development
Primary Organization
Seaport Therapeutics

Location New York, New York, United States
Regions Greater New York Area, East Coast, Northeastern US
Gender Male

LinkedIn View on LinkedIn

Antony Loebel is the current Chief Medical Officer and President of Clinical Development of Seaport Therapeutics. He previously worked at Sunovion Pharmaceuticals as a President and CEO. Anthony attended the University of Washington School of Medicine.

Jobs

Number of Current Jobs

Number of Past Jobs

Antony Loebel

has

current jobs as

Chief Medical Officer and President of Clinical Development

Seaport Therapeutics

and

Executive Officer & Head of Global Clinical Development

Dainippon Sumitomo Pharma

. Additionally,

Antony Loebel

has had

past jobs including

President and Chief Executive Officer

Sunovion Pharmaceuticals

Seaport Therapeutics Chief Medical Officer and President of Clinical DevelopmentJun 2024
Dainippon Sumitomo Pharma Executive Officer & Head of Global Clinical Development

Organization Name	Title At Company	Start Date	End Date
Sunovion Pharmaceuticals	President and Chief Executive Officer	Apr 2019	2023
Sunovion Pharmaceuticals	EVP & CMO	Dec 2011	Mar 2019
Dainippon Sumitomo Pharma	VP of Clinical Development	Aug 2007	Apr 2010

Related Hubs

Hub Name	CB Rank (Hub)
ARCH Venture Partners Portfolio Companies	77,056
Therapeutics Companies With More Than 100 Employees	16,519
Biotechnology Female Founded Public Companies	54,895
Advanced Research Projects Agency for Health Portfolio Companies	96,362
Therapeutics Public Companies	34,624
Northeastern US Public Companies With Fewer Than 1000 Employees	34,813
Biopharma Public Companies	32,655
Foresite Capital Portfolio Companies	80,476
United States Therapeutics Female Founded Companies	42,885
Invus Portfolio Companies	69,535